The Centers for Disease Control and Prevention (CDC) is reminding the public of the similarities and differences between the symptoms of COVID-19 and allergies amid allergy season....
Pharmaceutical giant Pfizer shared promising results Thursday regarding its COVID-19 booster dose for children aged 5 to 11. The company said that an additional shot of...
Two new Omicron subvariants are driving up COVID cases in New York | Fortune You need to enable JavaScript to view this site.
A new COVID-19 nasal spray will advance to human clinical trials soon after performing well and even doing better than currently available antibody treatments against SARS-CoV-2...
Companies are pulling out all the stops to lure employees back to the office. But they’re missing the biggest draw | Fortune You need to enable...
Pfizer CEO Albert Bourla on developing a COVID vaccine in less than a year | Fortune You need to enable JavaScript to view this site.
Cases of a new COVID-19 variant first detected at the start of the year continue to be reported across the globe, but health officials claim there...
Two studies published Monday concluded that the risk of heart inflammation following COVID-19 vaccination is quite low. A study published in the American Heart Association’s journal...
Shionogi COVID pill: Investors flee drugmaker on news of birth defect risk | Fortune You need to enable JavaScript to view this site.
Two-dose COVID-19 vaccines provided significant protection against hospitalization and death in people who previously battled an infection with the novel coronavirus before they got jabbed. A...
Recent Comments